Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

WE MAY HAVE TO CLEAN AFTER VACCINES

https://www.theguardian.com/us-news/2021/jun/11/cdc-covid-vaccines-mrna-heart-inflammation-reports

Congestive cardiac failure has become one of the major health challenges of the 21st century and new therapies are needed to address this problem. The concentration of vasoactive intestinal peptide (VIP) in the heart has been shown to decrease as fibrosis (the pathology leading to heart failure) increases and to become undetectable in end stage cardiomyopathy. We sought to determine whether replenishment of myocardial VIP might treat myocardial fibrosis and therefore represent a new therapeutic target.

https://pubmed.ncbi.nlm.nih.gov/31449808/

OR BETTER YET, GET A GOOD CHUNK OF THEIR MARKET

According to the report published by Allied market Research, the global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027.

https://www.globenewswire.com/en/news-release/2021/05/04/2222544/0/en/Vaccines-Market-Size-is-Expected-to-Hit-54-15-Billion-by-2027-Says-Allied-Market-Research.html